Articles dans des revues avec comité de lecture (39)
  1. 13. De Poorter, C., Baertsoen, K., Lannoy, V., Parmentier, M., & Springael, J.-Y. (2013). Consequences of ChemR23 heteromerization with the chemokine receptors CXCR4 and CCR7. PloS one, 8(2), e58075. doi:10.1371/journal.pone.0058075
  2. 14. Bondue, B., De Henau, O., Luangsay, S., Devosse, T., De Nadai, P., Springael, J.-Y., Parmentier, M., & Vosters, O. (2012). The chemerin/ChemR23 system does not affect the pro-inflammatory response of mouse and human macrophages ex vivo. PloS one, 7(6), e40043. doi:10.1371/journal.pone.0040043
  3. 15. Sohy, D., Yano, H., De Nadai, P., Urizar Andrieu, E., Guillabert, A., Javitch, J. A., Parmentier, M., & Springael, J.-Y. (2009). Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists. The Journal of biological chemistry, 284(45), 31270-31279. doi:10.1074/jbc.M109.054809
  4. 16. Richter, R., Casarosa, P., Ständker, L., Münch, J., Springael, J.-Y., Nijmeijer, S., Forssmann, W.-G., Vischer, H. F., Vakili, J., Detheux, M., Parmentier, M., Leurs, R., & Smit, M. J. (2009). Significance of N-terminal proteolysis of CCL14a to activity on the chemokine receptors CCR1 and CCR5 and the human cytomegalovirus-encoded chemokine receptor US28. The Journal of immunology, 183(2), 1229-1237. doi:10.4049/jimmunol.0802145
  5. 17. Gouwy, M., Struyf, S., Noppen, S., Schutyser, E., Springael, J.-Y., Parmentier, M., Proost, P., & Van Damme, J. (2008). Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events. Molecular pharmacology, 74(2), 485-495. doi:10.1124/mol.108.045146
  6. 18. Gaertner, H., Lebeau, O., Borlat, I., Cerini, F., Dufour, B., Kuenzi, G., Melotti, A., Fish, R. J., Offord, R., Springael, J.-Y., Parmentier, M., & Hartley, O. (2008). Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4. Protein engineering, design & selection, 21(2), 65-72. doi:10.1093/protein/gzm079
  7. 19. Boudry, C., Markine-Goriaynoff, N., Delforge, C., Springael, J.-Y., de Leval, L., Drion, P.-V., Russell, G., Haig, D. M., Vanderplasschen, A., & Dewals, B. (2007). The A5 gene of alcelaphine herpesvirus 1 encodes a constitutively active G-protein-coupled receptor that is non-essential for the induction of malignant catarrhal fever in rabbits. Journal of general virology, 88(Pt 12), 3224-3233. doi:10.1099/vir.0.83153-0
  8. 20. Sohy, D., Parmentier, M., & Springael, J.-Y. (2007). Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers. The Journal of biological chemistry, 282(41), 30062-30069. doi:10.1074/jbc.M705302200
  9. 21. Springael, J.-Y., Urizar Andrieu, E., Costagliola, S., Vassart, G., & Parmentier, M. (2007). Allosteric properties of G protein-coupled receptor oligomers. Pharmacology & therapeutics, 115(3), 410-418. doi:10.1016/j.pharmthera.2007.06.004
  10. 22. Springael, J.-Y., De Poorter, C., Deupi, X., Van Durme, J., Pardo, L., & Parmentier, M. (2007). The activation mechanism of chemokine receptor CCR5 involves common structural changes but a different network of interhelical interactions relative to rhodopsin. Cellular signalling, 19(7), 1446-1456. doi:10.1016/j.cellsig.2007.01.022
  11. 23. Kellenberger, E., Springael, J.-Y., Parmentier, M., Hachet-Haas, M., Galzi, J.-L., & Rognan, D. (2007). Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening. Journal of medicinal chemistry, 50(6), 1294-1303. doi:10.1021/jm061389p
  12. 24. Twizere, J.-C., Springael, J.-Y., Boxus, M., Burny, A., Dequiedt, F., Dewulf, J.-F., Duchateau, J., Portetelle, D., Urbain, P., Van Lint, C., Green, P. L., Mahieux, R., Parmentier, M., Willems, L., & Kettmann, R. (2007). Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling. Blood, 109(3), 1051-1060. doi:10.1182/blood-2006-06-026781
    13. << Précédent 1 2 3 4 5 6 7 8 Suivant >>